Gene expression analysis of dupuytren's disease: The role of TGF-β2

Journal of Hand Surgery: European Volume

Volumn 33, Issue 6, 2008, Pages 783-790

  Zhang, Andrew Y ^a,b   Fong, K D ^a,b   Pham, H ^a,b   Nacamuli, R P ^a,b   Longaker, M T ^a,b   Chang, J ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Dupuytren's disease; Microarray analysis; TGF gene expression

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ALPHA SMOOTH MUSCLE ACTIN; BETA1 INTEGRIN; COLLAGEN TYPE 1; COLLAGEN TYPE 5; COLLAGEN TYPE 8; COMPLEMENTARY DNA; FIBRONECTIN; HEAT SHOCK PROTEIN 47; LAMININ; MEMBRANE PROTEIN; OSTEONECTIN; RAB PROTEIN; RETINOIC ACID BINDING PROTEIN; RGS PROTEIN; SEPRASE; TENASCIN; THROMBOSPONDIN 2; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR SOX4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; CASE REPORT; CELL PROLIFERATION; CONTRACTURE; CONTROLLED STUDY; DUPUYTREN CONTRACTURE; FASCIOTOMY; FIBROBLAST; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PALMAR FASCIA; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

AGED; DUPUYTREN'S CONTRACTURE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA2; UP-REGULATION;

EID: 59749097505     PISSN: 17531934     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753193408091352     Document Type: Article

References (27)

1. Akman, HO, H Zhang, and MAQ Siddiqui (2001). Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cells. Blood, 98, 3324-3331.
2. Alioto, RJ, RN Rosier, RI Burton, and JE Puzas (1994). Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. Journal of Hand Surgery A, 19, 442-452.
3. Badalamente, MA, SP Sampson, LC Hurst, A Dowd, and K Miyasaka (1996). The role of transforming growth factor beta in Dupuytren's disease. Journal of Hand Surgery A, 21, 210-215.
4. Bailey, AJ, TJ Sims, G Gabbiani, S Bazin, and M LeLous (1977). Collagen of Dupuytren's disease. Clinical Science and Molecular Medicine, 53, 499-502.
5. Baird, KS, JF Crossan, and SH Ralston (1993). Abnormal growth factor and cytokine expression in Dupuytren's contracture. Journal of Clinical Pathology, 46, 425-428.
6. Bazin, S, M Lelous, and VC Duance (1980). Biochemistry and histology of the connective tissue of Dupuytren's disease lesions. European Journal of Clinical Investigations, 10, 9-16.
7. Berndt, A, H Kosmehl, D Katenkamp, and V Tauchmann (1994). Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology, 62, 55-58.
8. Berndt, A, H Kosmehl, and U Mandel (1995). TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochemical Journal, 27, 1014-1020.
9. Bornstein, P, A Agah, and TR Kyriakides (2004). The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. International Journal of Biochemistry and Cell Biology, 36, 1115-1125.
10. DeRisi, J, L Penland, and PO Brown (1996). Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nature Genetics, 14, 457-460.
11. DeRisi, JL, VR Lyer, and PO Brown (1997). Exploring the metabolic and genetic control of gene expression on a genomic scale. Science, 278, 680-686.
12. Eisen, MB, PT Spellman, PO Brown, and D Botstein (1998). Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America, 95, 14863-14868.
13. Gabbiani, G, and G Majno (1972). Dupuytren's contracture: Fibroblast contraction? An ultrastructural study. American Journal of Pathology, 66, 131-134.
14. Howard, JC, VM Varallo, and DC Ross (2004). Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren's contracture. Journal of Surgical Research, 117, 232-238.
15. Kawaguchi, N, C Sundberg, M Kveiborg, B Moghadaszadeh, and M Asmar (2003). ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating {beta}1 integrin function. Journal of Cell Science, 116, 3893 - 3904.
16. Kloen, P, CL Jennings, MC Gebhardt, DS Springfield, and HJ Mankin (1995). Transforming growth factor-β: Possible roles in Dupuytren's contracture. Journal of Hand Surgery A, 20, 101-108.
17. Kuhn, MA, WG Payne, PC Kierney, LL Pu, and PD Smith (2001). Cytokine manipulation of explanted Dupuytren's affected human palmar fascia. International Journal of Surgical Investigations, 2, 443-456.
18. Kuhn, MA, X Wang, WG Payne, F Ko, and MC Robson (2002). Tamoxifen decreases fibroblast function and downregulates TGFβ2 in Dupuytren's affected palmar fascia. Journal of Surgical Research, 103, 146-152.
19. Magro, G, S Lanzafame, and G Micoli (1995). Coordinate expression of alpha 5 beta 1 integrin and fibronectin in Dupuytren's disease. Acta Histochemica, 97, 229-233.
20. Margro, G, F Fraggetta, S Travali, and S Lanzafame (1997). Immunohistochemical expression and distribution of alpha2beta1, alpha6beta1, alpha5beta1 integrins and their extracellular ligands, type IV collagen, laminin and fibronectin in palmar fibromatosis. General and Diagnostic Pathology, 143, 203-208.
21. Menzel, EJ, H Piza, C Zielinski, AT Endler, and C Steffen (1979). Collagen types and anticollagen antibodies in Dupuytren's disease. Hand, 11, 243-248.
22. Peters, DG, AB Kassam, and E Feingold (2001). Molecular anatomy of an intracranial aneurysm: Coordinated expression of genes involved in wound healing and tissue remodeling. Stroke, 32, 1036-1042.
23. Roberts, AB, and MB Sporn (1995). Transforming growth factor-β. In RAF Clark (Ed.), The molecular and cellular biology of wound repair, 2nd Edn (pp. 275-308). New York: Plenum Press.
24. Tomasek, JJ, RJ Schultz, CW Episalla, and SA Newman (1986). The cytoskeleton and extracellular matrix of the Dupuytren's disease 'myofibroblast': An immunofluorescence study of a non-muscle cell type. Journal of Hand Surgery A, 11, 365-371.
25. Tomasek, JJ, RJ Schultz, and CJ Haaksma (1987). Extracellular matrix-cytoskeleton connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren's disease. Journal of Bone and Joint Surgery A, 69,1400-1407.
26. Tuxhorn, JA, GE Ayala, VC Smith, TD Dang, and DR Rowley (2002). Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clinical Cancer Research, 8, 2912 -2923.
27. Ulrich, D, K Hrynayschyn, and N Pallua (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Plastic and Reconstructive Surgery, 112, 1279-1286.